ATE292978T1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents

Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Info

Publication number
ATE292978T1
ATE292978T1 AT01958190T AT01958190T ATE292978T1 AT E292978 T1 ATE292978 T1 AT E292978T1 AT 01958190 T AT01958190 T AT 01958190T AT 01958190 T AT01958190 T AT 01958190T AT E292978 T1 ATE292978 T1 AT E292978T1
Authority
AT
Austria
Prior art keywords
nitrogen oxide
precursor
metabolism
composition containing
iron complexing
Prior art date
Application number
AT01958190T
Other languages
German (de)
English (en)
Inventor
Bernard Dugas
Original Assignee
Isocell S A
Bernard Dugas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell S A, Bernard Dugas filed Critical Isocell S A
Application granted granted Critical
Publication of ATE292978T1 publication Critical patent/ATE292978T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01958190T 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält ATE292978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (1)

Publication Number Publication Date
ATE292978T1 true ATE292978T1 (de) 2005-04-15

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958190T ATE292978T1 (de) 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Country Status (8)

Country Link
US (1) US6984624B2 (enExample)
EP (1) EP1303296B1 (enExample)
JP (1) JP2004520264A (enExample)
AT (1) ATE292978T1 (enExample)
AU (1) AU2001279922A1 (enExample)
DE (1) DE60110084D1 (enExample)
FR (1) FR2812200B1 (enExample)
WO (1) WO2002009740A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US8126524B2 (en) 2003-09-12 2012-02-28 Or-Nim Medical Ltd. Method and apparatus for noninvasively monitoring parameters of a region of interest in a human body
ATE336695T1 (de) * 2004-04-23 2006-09-15 Abb Research Ltd Modell und regelung eines müllverbrennungsverfahrens
ZA200702421B (en) * 2004-10-08 2008-09-25 Unilever Plc Iron complex for use in the treatment and/or prevention of nutritional disorders
US20090082305A1 (en) * 2005-03-30 2009-03-26 Kyowa Hakko Kogyo Co., Ltd. Method of improving storage stability of substance
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
JP5022454B2 (ja) * 2008-02-14 2012-09-12 森永乳業株式会社 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT726768E (pt) * 1993-11-02 2000-11-30 Us Health Utilizacao de compostos libertadores de acido nitrico para o fabrico de um medicamento para proteccao na lesao por isquemia-reperfusao
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
EP1017407A2 (en) * 1997-02-03 2000-07-12 Pharming Intellectual Property BV Useful properties of human lactoferrin and variants thereof

Also Published As

Publication number Publication date
FR2812200B1 (fr) 2003-01-03
DE60110084D1 (de) 2005-05-19
EP1303296A1 (fr) 2003-04-23
US20040033945A1 (en) 2004-02-19
AU2001279922A1 (en) 2002-02-13
WO2002009740A1 (fr) 2002-02-07
FR2812200A1 (fr) 2002-02-01
EP1303296B1 (fr) 2005-04-13
JP2004520264A (ja) 2004-07-08
US6984624B2 (en) 2006-01-10

Similar Documents

Publication Publication Date Title
WO2007035757A3 (en) Composition and method for treating iron deficiency anemia
ZA878952B (en) Metal complex-containing pharmaceutical agents
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
EP1311269A4 (en) PROCESS FOR USE OF DIKETOPIPERAZINES AND COMPOSITIONS THEREOF CONTAINING THEM
UA34768A (uk) Склад для обробки пар тертя
NO954441D0 (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
WO1999059640A3 (en) Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DE69834339D1 (de) Verwendung einer zusammensetzung die einen chelatbildner und eine antimikrobielle verbindung enthaltet zur behandlung von biofilmen
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
EP1053010A4 (en) COPOLYMER COMPOSITIONS FOR ORAL ADMINISTRATION
ATE143266T1 (de) Komplexe und chelate des azithromycins als antiulcus-mittel
ATE292978T1 (de) Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält
YU13301A (sh) Muskarinski agonisti i antagonisti
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
MXPA03001287A (es) Uso de complejos metalicos conteniendo perfluoroalquilo como medios de contraste en imagenes rm para la representacion de placas, tumores y necrosis.
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
TR199901782T2 (xx) Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
MXPA04004304A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.
GR20000100238A (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
DE60212424D1 (de) Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties